Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
Pharmaceutical and medical stocks fell sharply in early trading, with new industries down more than 13%, Hengrui medicine down more than 9%, Antu biology, Mindray medical and Yigou medicine down more than 7%, followed by Weili medical, Xinmai medical and Nanwei medicine.
This text is a result of machine translation.
Related companies：
Briefing Yesterday 07:48 AM
· Healthcare
Insiders: the regulatory letter of Hengrui pharmaceutical is about the regulatory requirements for the treatment of "capitalization of R & D expenses"
In depth
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Nov 10, 2021 01:18 PM
· Healthcare
Hengrui medicine rose in a straight line in the afternoon
Briefing Oct 26, 2021 11:02 AM
Monitoring of main funds of star mine: Top 10 list of early trading
Briefing Oct 12, 2021 05:44 PM
· Healthcare
Nippon instruments: the profit in the first three quarters is expected to drop by 58% - 63%
In depth
Healthcare
Mindray, the Dominant A-share Medical Device Maker: Not a COVID-19 Speculator
Mindray Medical (300760:SH) is the most expensive stock in the segment of Chinese medical devices so far. Now this giant is following the domestic healthcare reform and raising the high-tech tide with organic growth.
Jun 24, 2020 11:42 AM
Briefing Sep 02, 2021 07:05 PM
· Healthcare
Hengrui medicine: iodofol injection passed the consistency evaluation of generic drugs
See more
Read next
Financials, Technology · Analysis
WIM2021 New York: Speakers to Inspire the Most Innovative Minds
Yesterday 06:13 PM
Consumer Discretionary · Analysis
New Oriental Education's Pivot from Overregulated K-12 Industry Is Worth a Bet
Nov 25, 2021 06:18 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.